SCHEMBL4564684

SCHEMBL4564684

COc1ccc(Cn2cnc3c(NCCc4cc5cccc(Cl)c5c(-c5cc(C)on5)n4)ncnc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HPGD P15428 1/20 0.41
HTT P42858 3/20 0.40
TP53 P04637 2/20 0.38
MAPT P10636 2/20 0.38
YTHDC1 Q96MU7 1/20 0.38
ADORA2A P29274 3/20 0.38
TMIGD3 P0DMS9 2/20 0.38
ADORA1 P30542 2/20 0.38
ADORA2B P29275 1/20 0.38
LMNA P02545 1/20 0.38
CTSL P07711 2/20 0.38
PIK3CD O00329 1/20 0.37
MEN1 O00255 1/20 0.37
RECQL P46063 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CCNB2 O95067 1/20 0.37
CDK1 P06493 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4542862 0.87 HTT (0.45) HDAC1HDAC6HPGDHTTTP53
SCHEMBL3768963 0.85 HDAC1 (0.41) HDAC1HDAC6HPGDHTTMAPT
SCHEMBL4539338 0.83 CTSL (0.47) HDAC1HDAC6HPGDHTTTP53
SCHEMBL4534986 0.83 HDAC1 (0.44) HDAC1HDAC6HPGDHTTTP53
SCHEMBL4539184 0.83 HDAC1 (0.43) HDAC1HDAC6HPGDHTTTP53
SCHEMBL4530998 0.82 HDAC1 (0.47) HDAC1HDAC6HPGDHTTTP53
SCHEMBL4533401 0.81 HDAC1 (0.46) HDAC1HDAC6HPGDHTTTP53
SCHEMBL4542188 0.81 HDAC1 (0.43) HDAC1HDAC6HPGDHTTTP53
SCHEMBL4541032 0.81 MAPT (0.47) HDAC1HDAC6HPGDHTTTP53
SCHEMBL4539397 0.81 PDE10A (0.41) HDAC1HDAC6HPGDHTTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2637669-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF Infinity Pharmaceuticals, Inc. (US) 2013-09-18 EP disclosed
WO-2012064973-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2012-05-18 WO disclosed